Loading...
11 spironolactone COVID-19 controlled studies, 3 RCTs
77% improvement
for early treatment, RR
0.23
[0.08-0.66]
https://c19early.org/spmeta.html
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2+
Cadegiani
77%
0.23 [0.08-0.66]
recov. time
8 (n)
262 (n)
Improvement, RR [CI]
Treatment
Control
Cadegiani
83%
0.17 [0.06-0.51]
recov. time
8 (n)
262 (n)
Cadegiani
38%
0.62 [0.42-0.91]
viral time
8 (n)
262 (n)
Mareev (RCT)
11%
0.89 [0.65-1.22]
no recov.
33 (n)
33 (n)
CT1
Mareev (RCT)
39%
0.61 [0.14-0.97]
no recov.
14/24
20/21
CT1
Mareev (RCT)
8%
0.92 [0.77-1.09]
hosp. time
33 (n)
33 (n)
CT1
Mareev (RCT)
87%
0.13 [0.01-2.25]
viral+
0/17
3/13
CT1
Ersoy (ICU)
46%
0.54 [0.36-0.81]
death
14/30
26/30
ICU patients
Davarpanah
78%
0.22 [0.08-0.55]
hosp.
6/103
23/103
CT1
Davarpanah
64%
0.36 [0.21-0.60]
recov. time
103 (n)
103 (n)
CT1
Abbasi (SB RCT)
55%
0.45 [0.18-1.13]
death
5/51
19/87
Abbasi (SB RCT)
34%
0.66 [0.30-1.48]
ventilation
7/51
18/87
Abbasi (SB RCT)
19%
0.81 [0.42-1.59]
ICU
10/51
21/87
Abbasi (SB RCT)
47%
0.53 [0.39-0.72]
no recov.
51 (n)
87 (n)
Wadhwa (RCT)
72%
0.28 [0.09-0.85]
progression
4/74
9/46
Wadhwa (RCT)
49%
0.51 [0.27-0.95]
no disch.
13/74
16/46
Wadhwa (RCT)
18%
0.82 [0.67-1.00]
recov. time
74 (n)
46 (n)
Holt
-129%
2.29 [1.59-3.32]
death/ICU
16/31
148/658
Jeon
77%
0.23 [0.08-0.64]
cases
case control
MacFadden
7%
0.93 [0.88-0.98]
cases
n/a
n/a
Cousins (PSM)
81%
0.19 [0.06-0.65]
ventilation
731 (n)
731 (n)
Cousins (PSM)
66%
0.34 [0.17-0.68]
ICU
731 (n)
731 (n)
Cousins (PSM)
18%
0.82 [0.71-0.93]
death
390/12,504
479/12,504
Cousins (PSM)
12%
0.88 [0.79-0.99]
death
521/16,324
592/16,324
Cousins (PSM)
15%
0.85 [0.77-0.94]
death
671/20,690
783/20,690
Cousins (PSM)
17%
0.83 [0.77-0.91]
ventilation
936/12,504
1,118/12,504
Cousins (PSM)
17%
0.83 [0.77-0.89]
ventilation
1,212/16,324
1,459/16,324
Cousins (PSM)
10%
0.90 [0.84-0.95]
ventilation
1,524/20,690
1,701/20,690
Spironolactone COVID-19 outcomes
c19 early .org
October 2023
1 CT: study uses combined treatment
Favors spironolactone
Favors control
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit